Perfusion and metabolic scintigraphy with 123I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy

Konstantin Valerievich Zavadovsky, Marina O. Gulya, Yuri B. Lishmanov, Denis I. Lebedev

Результат исследований: Материалы для журналаСтатья

10 Цитирования (Scopus)

Аннотация

Objective: The objective of the study was to investigate the left ventricular (LV) myocardial perfusion and metabolism in patients with idiopathic dilated cardiomyopathy (DCM) and to identify the scintigraphic predictors of the efficacy of cardiac resynchronization therapy (CRT). Methods: The study comprised 63 patients with DCM and severe heart failure (NYHA class III–IV). Before CRT, all patients received gamma-scintigraphy with 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) and with 123I-β-methyl-iodophenyl pentadecanoic acid (123I-BMIPP) for evaluation of myocardial perfusion and metabolism, respectively. Before and after 6 months of CRT, all patients underwent echocardiography study to assess cardiac hemodynamics. Results: After 6 months of CRT, patients were divided into two groups: group 1 comprised responders in whom LV end systolic volume (LVESV) decreased by ≥15 % (n = 39); group 2 comprised non-responders in whom LVESV decreased by

Язык оригиналаАнглийский
Страницы (с-по)1-9
Число страниц9
ЖурналAnnals of Nuclear Medicine
DOI
СостояниеПринято/в печати - 12 фев 2016

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Подробные сведения о темах исследования «Perfusion and metabolic scintigraphy with <sup>123</sup>I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy». Вместе они формируют уникальный семантический отпечаток (fingerprint).

  • Цитировать